Immuneel Therapeutics raises $10.5M Series B (India, Jun 2026)
$10.5M
Rs 100 CroreGenerated social card
Headline
Immuneel Secures Rs 100 Crore to Expand Cancer Therapies - Siliconindia
About
Immuneel Therapeutics is a cancer-focused biotech startup that develops cell and gene therapies designed to treat complex cancers. The company aims to make advanced immunotherapy treatments more accessible to patients in India and other emerging markets, with a focus on scaling manufacturing and advancing research.
Article summary
Immuneel Secures Rs 100 Crore to Expand Cancer Therapies Siliconindia
Founder
Kiran Mazumdar-Shaw
Co-founder
Investors · 5
3 hidden